Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

165 Press Releases
DateTitleCompany
24 Sep 15 Amgen And Allergan Announce Positive Top-line Results From Phase 3 Study of Biosimilar Candidate ABP 215 Amgen ,
Published by
PharmiWeb.com
17 Sep 15 Amgen To Acquire Privately-Held Dezima Pharma Amgen ,
Published by
PharmiWeb.com
17 Sep 15 Amgen And Xencor Announce Strategic Collaboration In Cancer Immunotherapy And Inflammation Amgen ,
Published by
PharmiWeb.com
17 Sep 15 Amgen To Present At The Bank Of America Merrill Lynch Global Healthcare Conference Amgen ,
Published by
PharmiWeb.com
17 Sep 15 Amgen Highlights Key Clinical Data To Be Presented At European Cancer Congress 2015 Amgen ,
Published by
PharmiWeb.com
17 Sep 15 Amgen To Present At The Morgan Stanley Global Healthcare Conference Amgen ,
Published by
PharmiWeb.com
17 Sep 15 Amgen Submits Application To FDA For New Delivery Option For Monthly Administration Of Repatha™ (Evolocumab) Amgen ,
Published by
PharmiWeb.com
02 Sep 15 Cholesterol lowering agent Repatha (evolocumab) offers new way to help UK patients Amgen ,
Published by
PharmiWeb.com
01 Sep 15 Cholesterol-Lowering Treatment Repatha®? (Evolocumab) Offers New Way To Help UK Patients Amgen,
Published by
PR Newswire
01 Sep 15 Cholesterol-Lowering Treatment Repatha®? (Evolocumab) Offers New Way To Help UK Patients Amgen,
Published by
PR Newswire
25 Aug 15 Amgen Submits New Drug Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) Amgen ,
Published by
Pharmiweb.com
25 Aug 15 Amgen To Present New Long-Term Repatha™ (Evolocumab) Data Analysis At ESC Congress 2015 Amgen ,
Published by
Pharmiweb.com
25 Aug 15 Amgen Submits New Drug Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) Amgen,
Published by
PR Newswire
20 Aug 15 Amgen And University Of California, Berkeley Announce Multi-Year Partnership To Assist Cancer Patient Advocacy Organizations In Measuring Effectiveness Of Programs Amgen ,
Published by
Pharmiweb.com
18 Aug 15 Amgen And University Of California, Berkeley Announce Multi-Year Partnership To Assist Cancer Patient Advocacy Organizations In Measuring Effectiveness Of Programs Amgen,
Published by
PR Newswire
03 Aug 15 Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 Amgen,
Published by
PharmiWeb.com
31 Jul 15 Amgen Announces Appointment Of Fred Hassan To Board Of Directors Amgen ,
Published by
PharmiWeb.com
29 Jul 15 Amgen Announces 2015 Third Quarter Dividend Amgen ,
Published by
PharmiWeb.com
24 Jul 15 Amgen Submits Supplemental New Drug Application For Kyprolis® (Carfilzomib) In Relapsed Multiple Myeloma Amgen ,
Published by
PharmiWeb.com
25 Jul 15 FDA Approves Kyprolis® (carfilzomib) For Combination Use In The Treatment Of Patients With Relapsed Multiple Myeloma Amgen,
Published by
PharmiWeb.com
01 Jun 15 AMGEN APPOINTS CORINNE LE GOFF, SENIOR VICE PRESIDENT AND HEAD OF THE EUROPEAN REGION Amgen,
Published by
PharmiWeb.com
02 Jun 15 Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab Amgen,
Published by
PR Newswire
30 Mar 15 FDA Grants Amgen Priority Review for Kyprolis® (Carfilzomib) Supplemental New Drug Application for the Treatment of Relapsed Multiple Myeloma AMGEN,
Published by
PR Newswire
26 Jul 15 EUROPEAN COMMISSION APPROVES AMGEN’S NEW CHOLESTEROL-LOWERING MEDICATION REPATHA™ (EVOLOCUMAB), THE FIRST PCSK9 INHIBITOR TO BE APPROVED IN THE WORLD, FOR TREATMENT OF HIGH CHOLESTEROL AMGEN,
Published by
PharmiWeb.com
18 Jul 15 Amgen Announces Positive BLINCYTO® (blinatumomab) Phase 2 Study Results In Patients With Relapsed/Refractory Philadelphia Chromosome-Positive B-Cell Precursor Acute Lymphoblastic Leukemia Amgen ,
Published by
PharmiWeb.com
21 Jul 15 European Commission Approves Amgen's New Cholesterol-Lowering Medication Repatha™ (evolocumab), The First PCSK9 Inhibitor To Be Approved In The World, For Treatment Of High Cholesterol Amgen,
Published by
PharmiWeb.com
18 Jul 15 University of Utah gets recognized for spearheading American manufacturing and economic growth Amgen ,
Published by
PharmiWeb.com
29 Jul 15 Amgen Announces Webcast of 2015 Second Quarter Financial Results Amgen ,
Published by
PharmiWeb.com
15 Apr 15 FDA Approves Corlanor® (ivabradine) To Reduce The Risk Of Hospitalization For Worsening Heart Failure In Patients With Chronic Heart Failure AMGEN,
Published by
PR Newswire
06 Apr 15 European Commission Approves Amgen's Vectibix® (panitumumab) As First-Line Treatment In Combination With FOLFIRI Chemotherapy For Metastatic Colorectal Cancer AMGEN,
Published by
PR Newswire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.